Lori has metastatic renal cell carcinoma initiated on pazopa…
Lori has metastatic renal cell carcinoma initiated on pazopanib (a vascular endothelial growth factor [VEGF] inhibitor) one month ago and has been applying emollient BID to hands and feet. At their visit today, they report tingling and erythema (grade 2) on the palms of hands and soles of feet with inflammation and break-down of skin. What would be the most appropriate treatment of hand-foot-skin reaction toxicity at this point?
Read Details